Clinical Trials Directory

Trials / Unknown

UnknownNCT01493908

The Effect of Marketing Variable on Effect of Active Drugs

The Effect of Price and Marketing Variable on the Pain Controlling Effect of Active Drugs in a Clinical Trial.

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
220 (estimated)
Sponsor
Hadassah Medical Organization · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

The efficacy of the placebo effect has been proved in many prior studies by comparing the symptoms and measures of patients. Placebo has been proved to help in treating illnesses such as depression, stomach ulcer and chronic headaches. A Meta analysis checked 47 studies about placebo and showed great significance when a patient is treated with placebo pill, no active substance, just by activating conditioning and expectation mechanism in his body, thus providing to the healing process, and that is it's importance. In recent years studies established a relationship between marketing variables (such as price, label) to the efficacy of a product. In addition- a unique research run in 2008 showed a significant relationship between the marketing strategies and the efficacy of medication; more specifically, patients in this research experienced less (controlled) pain when treated with placebo medication introduced to them as more expensive than patients treated with placebo medication that was introduced to them as much cheaper. All patients were treated with the exact same medication. In the investigator's experiment the investigators design a laboratory experiment to determine if marketing factors could invoke the placebo effects described earlier. For the initial laboratory experiment, we decided to examine the difference in price, on the efficacy of an OTC analgesic through the mediation of low- voltage electrical pulses to the patient's wrist. The investigators study hypothesis is that marketing variables such as price and brand name will affect the therapeutic efficacy of an analgesic, i.e. a medicine will have greater influence when the patient is aware of its price compared to one who is not.

Conditions

Interventions

TypeNameDescription
DRUGHigh priceAcetaminophen label as high price
DRUGLow priceAcetaminophen label as low price
DRUGLow price participants aware paying partAcetaminophen label as low price; participants aware they are paying part of the full price
DRUGNo priceacetaminophen. No price - price issue not introduced to participants.
DRUGFree of chargeAcetaminophen. participants aware the product is free of charge

Timeline

Start date
2012-01-01
Primary completion
2012-12-01
Completion
2013-06-01
First posted
2011-12-16
Last updated
2011-12-16

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT01493908. Inclusion in this directory is not an endorsement.